CD1a自反应性T细胞感知皮肤屏障受损
研究探讨CD1a在特应性皮炎(AD)发病中的作用,采用人体皮肤激发、单细胞与空间转录组及功能免疫学方法。发现AD患者皮肤过敏原激发诱导CCL17和CCL22升高,促进CCR4+ T细胞迁移;病变皮肤中活化CD1a+树突状细胞持续存在并表达中性鞘磷脂酶,加工长链鞘磷脂驱动Th2细胞CD1a自反应性。结论提示CD1a自反应性T细胞通过感知鞘磷脂循环改变来监测慢性皮肤屏障受损。
要点
- AD皮肤过敏原激发后CCL17/CCL22升高,招募CCR4+ T细胞。
- 病变皮肤中活化CD1a+树突状细胞持续存在,与Th2细胞共定位。
- CD1a+树突状细胞表达中性鞘磷脂酶,驱动Th2细胞CD1a自反应性。
核心结论
- CD1a自反应性T细胞通过检测鞘磷脂循环活性改变来感知慢性皮肤屏障受损,与特应性皮炎及相关疾病发病相关。
研究设计与样本
- 采用人体皮肤激发、单细胞与空间转录组学及功能免疫学方法评估CD1a在AD发病中的作用。
主要发现
- AD患者皮肤过敏原激发诱导CCL17和CCL22浓度升高,促进CCR4+ T细胞迁移。
- 人AD病变皮肤单细胞蛋白转录组学识别出活化CD1a+树突状细胞是CCL17/22的主要来源,该细胞群持续存在。
- 空间组织分析显示这些CD1a+树突状细胞主要位于病变表皮下微区簇,与不同Th2细胞亚群共定位。
- 活化皮肤树突状细胞表达中性鞘磷脂酶,加工抑制性长链鞘磷脂以驱动Th2细胞CD1a自反应性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: T cells are often enriched at barrier tissues, yet little is known of their roles in barrier sensing and relevance to associated disease. CD1a is a Major Histocompatibility Complex class I-like molecule expressed by Langerhans cells, which forms complexes with lipid antigens to facilitate recognition by non-classical CD1a-reactive T cells. OBJECTIVES: Langerhans cells are altered in lesional atopic dermatitis (AD) skin, but the role of CD1a in disease pathogenesis has not been extensively investigated. METHODS: Human skin challenge, single cell and spatial transcriptomic based approaches and functional immunology were used to assess the role of CD1a in AD pathogenesis. RESULTS: Skin allergen challenge in individuals with AD induced skin CCL17 and CCL22 concentrations that promoted CCR4+ T cell migration. Single cell resolution proteo-transcriptomics from human lesional AD skin tissue identified a dominant CCL17/22 source as a persistent population of activated skin CD1a+ dendritic cells (DCs) previously shown to be transiently enriched in human skin wounds. Single-cell resolution spatial tissue analyses showed that these cells were predominantly located within lesional sub-epidermal microcompartment clusters co-localising with distinct subpopulations of Th2 cells. Activated skin DCs expressed neutral sphingomyelinase, which processed inhibitory long chain sphingomyelin to drive Th2 cell CD1a-autoreactivity. CONCLUSIONS: In summary, the findings are consistent with human CD1a-autoreactive T cells sensing of chronic skin barrier compromise through detection of altered sphingomyelin cycle activity, with implications for the pathogenesis of atopic and related disease.
引用
- Ottakandathil Babu R, Nahler J, Dooley K, et al. CD1a-autoreactive T cell sensing of skin barrier compromise. Br J Dermatol. 2026. PMID: 42710064. doi:10.1093/bjd/ljag391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。